Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
Abiomed is recalling Automated Impella Controllers (AICs) after a faulty purge flag component was linked to 37 serious injuries and 3 deaths. The defect can trigger alarms and delay mechanical circulatory support — a serious risk for hemodynamically unstable patients. Abiomed is reaching out to customers with interim guidance and plans to replace the faulty parts through maintenance visits.
Abiomed has alerted healthcare customers to a critical safety issue with its Automated Impella Controllers (AICs) — the primary interface for the widely used Impella mechanical circulatory support device. The FDA issued an Early Alert on August 26, 2026, after the company identified failures in the purge flag component within the purge pressure sensor assembly, which can cause purge cassette recognition errors and trigger alarms requiring an AIC swap.
The concern is especially acute for patients in hemodynamic crisis: if a failure occurs before a procedure begins, the required AIC exchange could delay the delivery of life-saving circulatory support. Abiomed plans to fix the issue by replacing the purge flag and retainer components, either during annual preventive maintenance or via direct outreach from its service team.
By the Numbers:
Why it matters: The Impella is a go-to device in high-risk cardiac interventions and cardiogenic shock management. A controller failure in these high-stakes moments can have life-or-death consequences, making rapid awareness and interim safety steps essential for cardiac care teams.
